All those aged 18 or above and have completed nine months after the administration of the second dose, will be eligible for the booster dose
09 Apr 2022 7:00 AM
Studies show a booster dose at least temporarily revs up antibodies to levels that offer the best chance at avoiding symptomatic infection
06 Jan 2022 12:43 PM
Sharing data about vaccinations, Gandhi there is a daily shortfall of 55.3 million doses
22 Dec 2021 12:58 PM
The booster dose issue is likely to be discussed in the next meeting of the NTAGI
23 Nov 2021 1:08 AM
For Pfizer and Moderna, the boosters could be more profitable than the original doses because they won’t come with the R&D costs
26 Sep 2021 10:48 AM
FDA determined that transplant recipients and others with a similar level of compromised immunity can receive a third dose of the vaccine
13 Aug 2021 12:38 PM
IIMS Delhi started the clinical trials of the third dose of the COVAXIN, as a booster dose, six months after administering the second dose
10 Jun 2021 4:15 PM